Study Background The purpose of this study is to measure the effects of transcranial magnetic stimulation on symptoms of bipolar depression. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depression Disorder (MDD). For this study, researchers will be testing an investigative form of TMS called accelerated intermittent theta burst (aiTBS) to evaluate its effectiveness in reducing symptoms of depression. Your participation in this study may help develop better treatments for bipolar disorder in the future. Join today and be compensated up to $185 in e-gift cards to retailers! |